Five Questions About Protopic (tacrolimus) Ointment
... NIH Publication No. 03-4272. Revised April 2003, page 3 Eczema/Atopic Dermatitis, American ... Accessed October 21, 2008, page 1 Handout on Health: Atopic Dermatitis. ... NIH Publication No. 03-4272. Revised April 2003, page 3 Protopic(R) (tacrolimus) Ointment full ...Zinc oxide gives green shine to new photoconductors
... pages are packed very tightly. Each organic page -- which can be one of thousands of different ... converted to zinc oxide. Each zinc oxide page is a nanometer thick while the organic page is one to two nanometers thick, depending on the ...Genetic information personalizes warfarin prescribing
... personalized medicine in the Badger State. page also plays a key role in the initiative. ... variables significantly improved dosing," page says. "Adding genetic information improved the ... by the National Institutes of Health. page says the study is a perfect example of the kinds ...Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich
... [the white paper download page __title__ download the free electronica white ... [the registration page __title__ discount electronica online ... [electronica 2008 home page __title__ electronica 2008 home page] Editorial ...Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.
... to adjusted sales growth can be found on page 10. -- Operating And Pretax Margins Both ... the Supplemental Financial Information section on page 10. Reported sales increased 14.6% and 13.4% ... the Supplemental Financial Information section on page 11. Reported diluted EPS for 2007's fourth ...Hologic Announces First Quarter Fiscal 2008 Operating Results
... webcast of the call on the investor relations page of the Company's website at ... will also be available on the investor relations page of the Company's website ... call will be posted in the investor relations page of the Company's website at ...Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results
... reflected as discontinued operations. (b) See page 5 for a reconciliation of earnings per share ... of our interest rate swap agreements. See page 9 for further details of our interest rate ... as of September 30, 2007 was 87.4%. See page 16 for additional information on our ...Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
... to adjusted sales growth can be found on page 10. -- Margins Continued Strong As Pretax ... and year-to-date periods can be found on page 11. Outlook: -- Full year 2007 sales are ... the Supplemental Financial Information section on page 10. Reported sales increased 14.0% and 13.0% for ...Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
... will be webcast live with the webcast available via the investor relations page of the company website. Meeting details are as follows: ... live webcast will be available via the investor relations page of the company website at www.Oxybiomed.com or directly at: ...WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com . ... results of operations and prospects, see "Risk Factors" beginning on page 10 of our 2007 Annual Report on Form 20-F. Our results of operations for ...Stanford writes in world's smallest letters
... offered a $1,000 prize for anyone who could find a way to rewrite a page from an ordinary book in text 25,000 times smaller than the usual size (a ... Fabian Pease, used electron beam lithography to engrave the opening page of Dickens' A Tale of Two Cities in such small print that it could be read ...WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com . ... results of operations and prospects, see "Risk Factors" beginning on page 10 of our 2007 Annual Report on Form 20-F. Any projections in this ...ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments
... list of ingredients and benefits visit our Dermocapsule Serum product page to view individual serums or Treatment Mask product page to view individual masks. Expect to see a new lineup of Dermocapsule ...WuXi PharmaTech Announces Third Quarter 2008 Results
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com . About WuXi ... results of operations and prospects, see "Risk Factors" beginning on page 10 of our 2007 Annual Report on Form 20-F. Our results of operations for ...Shire's New Product Portfolio Delivers Strong Quarterly Performance
... that these Non GAAP financial measures are useful to investors, see page 5. For a reconciliation of these Non GAAP financial measures to the most ... the tax effect of items excluded from Non GAAP income as outlined on page 24, principally the IPR&D charge in respect of FIRAZYR in non EU markets ...Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations
... media. The profile pages, accessible from the Healthcare Scoop home page and from individual posts or stories, allow participating ... said Jan Malcolm, CEO, Courage Center, which sponsors a profile page on the Healthcare Scoop. "That's why we're excited to be a partner with ...WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com . About WuXi ... results of operations and prospects, see "Risk Factors" beginning on page 10 of our 2007 Annual Report on Form 20-F. Our preliminary results of ...Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
... by the restructuring charge described in Note 1 above. (3) Refer to page 6 for a description of the adjustment and a reconciliation to GAAP ... and manufacturing operations outside of the United States. (3) Refer to page 8 for a description of the adjustments and a reconciliation to GAAP ...WuXi PharmaTech Announces First Quarter 2008 Results
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com . About ... results of operations and prospects, see "Risk Factors" beginning on page 15 of the related prospectus. Our actual results of operations for the ...Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners
... programs in clinical lab sciences. The Labs Are Vital Facebook page continues to connect interested, career-minded high school and college ... Additional Resources: Labs Are Vital Facebook group page ( http://www.facebook.com/group.php?gid=12659610076 ) ...WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com . About ... results of operations and prospects, see "Risk Factors" beginning on page 11 of our prospectus. Our actual results of operations for the fourth ...Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
... (closed Nov. 19, 2007) and other specified items (see table below on page 13). For the 2006 fourth quarter, Schering-Plough reported net income of ... percent of global cholesterol joint venture net sales - see table below on page 19 and hereinafter referred to as "adjusted sales") would have totaled ...WuXi PharmaTech Announces Second Quarter 2007 Results
... the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com . About ... results of operations and prospects, see "Risk Factors" beginning on page 11 of our prospectus. Our actual results of operations for the second ...InterMune to Present at Canaccord Adams Conference
... a.m. EDT. To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the ...OncoGenex Reports Second Quarter 2009 Financial Results
... today to provide a business update and discuss the first quarter results. A live webcast will be available through the Events and Presentations Web page found in the Investor Relations section of the OncoGenex Web site at www.ir.oncogenex.com . Alternatively, you may access the live conference call ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... comparable financial measures prepared in accordance with US GAAP, see pages 22 and 23. FINANCIAL SUMMARY Second Quarter 2009 (see page 6 for full Financial Results) - Product sales excluding ADDERALL XR(R) were up 20% (up 27% at CER) to $491 million, following continued ...